Clinical trial for Hyposmia
Official title Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19
ClinicalTrials.gov ID: NCT05384561
What this study is testing
- What it's testing
- The study wants to see if a 12‑week smell‑training program improves persistent loss or distortion of smell after COVID‑19, and whether one set of scents works better than another.
- Who it's for
- Adults who still have reduced or altered sense of smell several weeks after a COVID‑19 infection.
- What's involved
- Participants will smell four specific scents twice daily for 12 weeks, attend study visits for smell tests (Sniffin’ Sticks and UPSIT) and fill out questionnaires about their smell experience.
- Time commitment
- The study lasts about three months with regular visits for testing and questionnaire completion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction
- Willing and able to provide written informed consent
- Understand and read the French language
- Have an internet connection and a working email address
You likely can't join if
- Anosmia and hyposmia pre-covid-19
- Be known chronic rhinosinusitis with or without nasal polyposis
- Have received radiotherapy or chemotherapy for Head and Neck Tumors
- Have a diagnosis of Alzheimer's, Parkinson's, multiple sclerosis or any other neurodegenerative disease 5. Have a brain tumor or ENT diagnosis 6.
The study team makes the final eligibility decision.
Where it is enrolling
- Trois-Rivières, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Trois-Rivières, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.